The phase IV open label, uncontrolled, single group assignment, efficacy study currently recruiting participants with an estimated enrollment of 60. The study director is Anne Kvistgaard, MSc from Vivostat.
Vivostat Platelet Rich Fibrin (PRF) is second generation Vivostat product designed for the preparation and application of autologous fibrin sealant. By combining a fibrin sealant solution with a platelet concentrate, it is possible to have a carrier, a controlled release and a medium for vascular ingrowth. Vivostat PRF contains a variety of potent growth factors that stimulate fibroblast proliferation and tissue synthesis.